Learn More
Apexbio Technology LLC VX-680 (MK-0457,Tozasertib) 639089-54-6 250mg

Supplier: Apexbio Technology LLC A4111250
VX-680 (also known as MK-0457 or tozasertib CAS 639089-54-6) is a small-molecule inhibitor discovered via molecular screening characterized by its broad inhibitory activity against aurora kinases (pan-aurora inhibitor) In addition to targeting aurora kinases VX-680 also inhibits several other kinases including Src GSK3 Flt3 JAK2 and both wild-type and T315I mutant forms of BCR-Abl It exerts its effect by binding to the inactive conformation of non-aurora kinases resulting in suppression of kinase activation In cellular assays and xenograft models VX-680 has demonstrated significant anti-proliferative activity across diverse tumor types such as ovarian renal thyroid oral squamous cell carcinomas CML AML and multiple myeloma supporting its utility in cancer research
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.